Mosul University
  • Register
  • Login
  • العربیة

Iraqi Journal of Pharmacy

Notice

As part of Open Journals’ initiatives, we create website for scholarly open access journals. If you are responsible for this journal and would like to know more about how to use the editorial system, please visit our website at https://ejournalplus.com or
send us an email to info@ejournalplus.com

We will contact you soon

  1. Home
  2. Volume 17, Issue 1
  3. Authors

Current Issue

By Issue

By Subject

Keyword Index

Author Index

Indexing Databases XML

About Journal

Aims and Scope

Editorial Board

Editorial Staff

Facts and Figures

Publication Ethics

Indexing and Abstracting

Peer Review Process

News

Guide to reviwers

In-vitro Examination of The Potential Antibacterial Activity of Simvastatin

    Hani Almukhtar Hiyam A. Altaii Musab M. Khalaf

Iraqi Journal of Pharmacy, 2020, Volume 17, Issue 1, Pages 75-92
10.33899/iphr.2020.167599

  • Show Article
  • Download
  • Cite
  • Statistics
  • Share

Abstract

Background: Statins are group of medicines that block mevalonate pathway by competitive inhibition of the rate limiting enzyme hydroxy-methylglutaryl-CoA reductase (HMG-CoA). Statins additionally inhibit the biosynthesis of important isoprenoid intermediates which have a role in peptidoglycan synthesis and cell growth. Several in-vivo and in-vitro studies have shown that certain type of statin family possess antibacterial activity in bacteraemia and sepsis.
Method: Two gram-positive pathogenic bacterial strain Staphylococcus aureus and Bacillus species were used for examining the antimicrobial activity of the lipophilic simvastatin using nutrient agar and nutrient broth and results were calculated by measuring the clear zone around the paper disk and compared with those obtained by the antibiotics, amoxycillin and ceftriaxone.
Results: Data have shown that simvastatin 1, 3, and 10 and 30 μM inhibited both Staphylococcus aureus and bacillus species, it exhibited inhibitory zone of (17.9 ± 0.6 mm) and (16.9 ± 0.3 mm), respectively.
Conclusion: the lipid soluble simvastatin, with relatively higher concentration than those obtained in-vivo, caused a significant inhibition of both Staphylococcus aureus bacteria and bacillus species.
Keywords:
    Simvastatin antibacterial Staphylococcus aureus
  • PDF (381 K)
  • XML
(2020). In-vitro Examination of The Potential Antibacterial Activity of Simvastatin. Iraqi Journal of Pharmacy, 17(1), 75-92. doi: 10.33899/iphr.2020.167599
Hani Almukhtar; Hiyam A. Altaii; Musab M. Khalaf. "In-vitro Examination of The Potential Antibacterial Activity of Simvastatin". Iraqi Journal of Pharmacy, 17, 1, 2020, 75-92. doi: 10.33899/iphr.2020.167599
(2020). 'In-vitro Examination of The Potential Antibacterial Activity of Simvastatin', Iraqi Journal of Pharmacy, 17(1), pp. 75-92. doi: 10.33899/iphr.2020.167599
In-vitro Examination of The Potential Antibacterial Activity of Simvastatin. Iraqi Journal of Pharmacy, 2020; 17(1): 75-92. doi: 10.33899/iphr.2020.167599
  • RIS
  • EndNote
  • BibTeX
  • APA
  • MLA
  • Harvard
  • Vancouver
  • Article View: 326
  • PDF Download: 187
  • LinkedIn
  • Twitter
  • Facebook
  • Google
  • Telegram
  • Home
  • Glossary
  • News
  • Aims and Scope
  • Privacy Policy
  • Sitemap
This journal is licensed under a Creative Commons Attribution 4.0 International (CC-BY 4.0)

Powered by eJournalPlus